Objective: Methyleneterahydrofolate reductase (MTHFR) A1298C polymorphism has been reported a risk factor for nonsyndromic cleft/palate (NSCL/P) in several published articles but results were inconclusive. To confirm the association between maternal MTHFR A1298C polymorphism and NSCL/P risk, a meta-analysis was conducted. Method: Case control articles for maternal MTHFR A1298C polymorphism and NSCL/P risk were identified by search of databases including PubMed, Google Scholar, Elsevier and Springer Link for the period up to December, 2013. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to assess the association. Results: Meta-analysis of ten included studies showed that there was no significant association between maternal MTHFR A1298C polymorphism and risk of NSCL/P under five genetic models (for C versus A, OR= 1.007, 95 % CI= 0.89-1.13, P=0.90; for CC versus AA, OR=0.851, 95 % CI = 0.63-1.15, P=0.30.; for AC versus AA, OR= 1.033, 95 % CI= 0.88-1.21, P= 0.69; for CC+AC versus AA, OR= 1.005, 95 % CI= 0.86-1.17, P=0.94; for CC versus AC+AA, OR= 0.86, 95 % CI= 0.64-1.15, P= 0.32). Conclusion: In conclusion, results of present meta-analysis demonstrate that maternal MTHFR A1298C polymorphism may not be a risk factor for developing NSCL/P in offspring. Further studies with large sample sizes are needed to evaluate the association of maternal MTHFR A1298C polymorphism with NSCL/P in more detail.
INTRODUCTION
Nonsyndromic cleft lip with or without cleft palate (NSCL/P)(OMIM 119530) is one of the most common congenital malformation with the global prevalence ranging between 1 in 300 and 1 in 2000 depending upon geographical origin, ethnicity, and socioeconomic status. 1 The frequency of NSCL/P has been found to decrease in the offspring of mothers who have received prenatal dietary supplementation with multivitamins, [2] [3] [4] [5] [6] suggesting that one or more vitamins may be of importance in the pathogenesis or prevention of NSCL/P. The effectiveness of maternal folic acid supplementation during pregnancy in reducing the frequency of neural tube defects (NTD) 7, 8 led to speculation that folic acid might play a similar role in craniofacial closure defects such as NSCL/P. 2, 3 Twin and family studies suggested that genetic factors play an important role in the etiology of NSCL/P. Furthermore, it has become increasingly clear that NSCL/P is a genetically complex trait, which is likely to be determined by several susceptibility loci acting in a multiplicative fashion, including genes such as: methylenetetrahydrofolate reductase (MTHFR).
MTHFR is key enzyme of folate and methionine metabolic cycles. It catalyzes the conversion of 5,
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A meta-analysis 10-methylenetetrahydrofolate to 5-methylenetetrahydrofolate reductase, which donates methyl group for the conversion of homocysteine to methionine. The methyl cycle supplies 1-carbon units critical for a variety of methylation reactions essential for proper gene expression and maternal and paternal imprinting by methylated DNA. The human MTHFR gene is 20 kb long (20,336 bp) and mapped at 1p36.3 (OMIM 607093), having 11 exons. Several single nucleotide polymorphisms (SNPs) in the MTHFR gene have been identified. Among which the most commonly studied polymorphisms are C677T in exon 4 and A1298C in exon 7.
9,10 These two polymorphisms were shown to be associated with reduced enzyme activity.
A1298C allele frequency differs greatly in various ethnic groups of the world. The prevalence of the A1298C homozygote variant genotype ranges from 7 to 12% in White populations from North America and Europe. Lower frequencies have been reported in Hispanics (4 to 5 %), Chinese (1 to 4 %) and Asian populations (1 to 4%). 11, 12 Several studies have explored the impact of maternal MTHFR A1298C polymorphism NSCL/P, but the association is conflicting. [13] [14] [15] [16] [17] To better understand these issues, a comprehensive meta-analysis was conducted to clarify the quantitative association between the maternal MTHFR A1298C polymorphism and risk of NSCL/P.
METHODS

Article search
Comprehensive search was conducted in the Pubmed, Google Scholar, Elsevier and Springer Link databases from their inception through December, 2013. Following search terms were used: 'MTHFR', 'A1298C', 'methylenetetrahydrofolate reductase', 'polymorphism', 'Cleft lip', and Cleft palate' and 'NSCL/P'. There was no language limitation. All references cited in those included studies were also reviewed to identify additional published articles not indexed in common databases.
Inclusion criteria were following: (1) study should be published in a peer-reviewed journal; (2) studies had sufficient data to calculate the odds ratio (OR) with a confidence interval (CI) and a P-value, (3) study should be case control, (4) should used the relevant genotyping protocols or provided reference to them, (5) used healthy individuals as controls. The major reasons for exclusion of studies were (1) only case studies, (2) review, conference abstract, letter to editor and editorials, and (3) containing overlapping data.
Data extraction
Information was carefully extracted from all eligible studies according to the inclusion criteria listed above.
The following data were collected from each study: first author's family name, year of publication, country, ethnicity, genotyping method, sample size, and numbers of genotype A1298C for both cases and controls, respectively.
Statistical analysis
In the meta-analysis of MTHFR A1298C polymorphism, the overall association of the C allele with risk of NSCL/P was evaluated in comparison with the A allele (Allele contrast model). Also, the contrasts of homozygote CC versus AA (homozygote model), AC versus AA (co-dominant model), CC versus AC+AA (recessive model) and CC+AC versus AA (dominant model) were examined.
The associations were indicated as a pooled odds ratio (OR) with the corresponding 95% confidence interval (CI). The heterogeneity between studies was tested using the Q-statistic, which is a weighted sum of the squares of the deviations of individual study OR estimates from the overall estimate. 18, 19 When the ORs are homogeneous, Q follows a chi-squared distribution with r -1 (r is the number of studies), degrees of freedom (df). When P<0.50 then the heterogeneity was considered to be statistically significant. Heterogeneity was quantified with the I 2 metric (I 2 = (Q -df)/Q), which is independent of the number of studies in the meta-analysis. I
2 takes values of between 0 and 100%, with higher values denoting a greater degree of heterogeneity. 19, 20 The pooled OR was estimated using fixed effects (FE) 21 and random effects (RE) 22 models. Random effects modeling assume a genuine diversity in the results of various studies, and it incorporates a between-study variance into the calculations. Hence, when there is heterogeneity between studies then the pooled OR is preferably estimated using the RE model.
19,23
Publication bias
Funnel plots were drawn to estimate the publication bias, in which the standard error (SE) of log (OR) of each study and precision of log (OR) of each study were plotted against its log (OR). The funnel plot asymmetry was assessed with Egger's test. 24 Publication bias P<0.05 was considered statistically significant. All analyses were performed using the computer program MIX version 1.7.
25
A p value less than 0.05 was considered statistically significant, and all the p values were two sided.
RESULTS
Study characteristics
Details of the included studies were given in table 1. Total ten studies were found to be suitable for the inclusion in the present meta-analysis. [13] [14] [15] [16] [17] [26] [27] [28] [29] [30] All these ten studies were performed in different countries-Argentina, 26 India, 16 Norway, 13 Ireland, 15 Italy, 14 Netherlands, 28 Thailand, 27 Ukraine, 29 Turkey, 30 and Venezuela. 17 In one study 16 reported only allele numbers (Table 1) . In only seven studies 13,14,17, 27-30 odds ratio was above one.
Summary statistics
The frequencies of the genotypes MTHFR 1298AA and 1298AC were the highest in both cases and controls, and allele A was the most common ( Table 2 ). The prevalence of allele C was 26.48% and 31.99% for the CL/P case mothers and control groups, respectively. The percentage frequency of CC genotype among case mothers and controls was 6.77% and 10.29%, respectively whereas prevalence of AC heterozygote among case mothers was 39.84% and 43.43% in controls. The prevalence of AA homozygote among CL/P case mothers and controls was 53.39% and 46.28%, respectively. In all the studies, distribution of genotypes in the control group was in Hardy Weinberg Equilibrium.
Meta-analysis
Mutant allele (C) did not show any significant association with NSCL/P in both fixed effect (p = 0.90, OR=1.007, 95% CI = 0.89-1.13) and random effect (p =0.90, OR= 1.007, 95% CI =0.89-1.13) models (Figure 1 ). In cumulative analysis using fixed and random effect models, the association of mutant 'C' allele with NSCL/P remained insignificant statistically with the addition of each study. Odds ratio for mutant genotypes (CC+AC)
showed no association with NSCL/P adopting both fixed (p =0. Figure 2 and all funnel plots were symmetrical.
DISCUSSION
There is considerable evidence suggesting that folate related genes play a role in the etiology of nonsyndromic facial clefts. Nonsyndromic clefts are complex traits and it is likely that genetic factors interact with environmental factors. Folate has long been considered one such factor in number of observational studies. [2] [3] [4] [5] 7, 8, 15, 31 Maternal folic acid supplementation in early pregnancy has been suggested to play a role in the prevention of nonsyndromic orofacial cleft, i.e. cleft lip with or without cleft palate (CL/P).
Martinelli et al 32 suggested that the variants of the MTHFR gene, considered to be a cause of reduced efficiency of folate utilization, could be an important risk factor for CL/P. Wong et al. 33 observed that maternal hyperhomocysteinemia may be a risk factor for having CL/P offspring. Considering that one of the effects of the reduced MTHFR activity is the hyperhomocysteinemia. Insufficient DNA synthesis and methylation by the mother could damage the developing embryo.
Meta-analysis is a powerful tool for analyzing cumulative data of studies where the individual sample sizes are small and the statistical power low. 34 Several meta-analysis studies illustrate the utility of the technique in identifying genes of small effects like MTHFR with phenotypes like -NTD, 35 Down syndrome, 36 Cardiovascular disease, 37 Migraine, 38 Schizophrenia, 39 bipolar disorder, 40 and depression. 41 The present meta-analysis (including 1019 case mothers and 16494 controls) was performed to assess the relationship between MTHFR A1298C polymorphism and NSCL/P with ten published case control studies, but no significant association was found in the total population. The main strength of the present study was that heterogeneity and publication bias were not observed. As with all meta-analyses, present analysis had also several limitations that must be acknowledged. Firstly, sample sizes of some included studies are rather small and they do not have adequate power to detect the possible risk for MTHFR A1298C polymorphism. 13, 29, 30 Secondly, main analysis was based on unadjusted estimates owing to the lack of adjusted estimates. However, a more precise analysis could be performed if adjusted estimates were available in all studies. Further owing to the limited evidence available on other folate gene polymorphisms; this review was restricted to the only one MTHFR polymorphism. Finally, data were not stratified by folate intake, ethinicity, and other suspected factors. Therefore, a more precise analysis should be conducted if enough data were available.
